City
Epaper

Anti Covid Nano Vaccine successful shows success in mice trials

By Lokmat English Desk | Updated: March 1, 2023 18:27 IST

Open in App
1 / 5
Researchers have used the body’s own immune cells to develop a nano-vaccine against COVID-19, according to a new study conducted in mice.
2 / 5
Unlike currently used vaccines, which use synthetic materials or adenovirus to package and deliver antigens, the researchers from Indian Institute of Technology (IIT), Delhi have taken a step forward towards next-generation vaccine for COVID-19, the study said.
3 / 5
According to the study, this naturally derived nano-vaccine developed by the researchers could have several advantages over currently approved vaccines.
4 / 5
It will minimise the chance of blood clotting, which was otherwise observed in vaccinated individuals, the study said.
5 / 5
Since the onset of the COVID-19 outbreak, scientists from around the world have been studying the disease and its epidemiology to develop effective vaccines. The immune response elicited by this vaccine was tested in mice.
Tags: Coronavirus VaccineAnti Covid Nano Vaccine
Open in App

Related Stories

HealthHow Serious Are the Side Effects of the AstraZeneca Vaccine, Named Covishield in India? Here Are the Facts.

HealthCovishield Offers Stronger Shield than Covaxin: Study

HealthHypervaccination: German Man Receives 217 COVID-19 Vaccine Shots in 29 Months, Shock Researchers

BusinessCOVID vaccine maker Adar Poonawalla to buy London’s most expensive house

Health"Not Covid vaccine": ICMR on rising number of sudden deaths among Indian youths

Health Realted Stories

HealthSleep Health: Midnight Screen Time Could Be Damaging Your Health; Here's Why

HealthPedestrians, cyclists among over 330K deaths from road crashes in SE Asia in 2021: WHO

HealthWell-being of nurses linked with strength of health systems, national growth: JP Nadda

HealthChennai corporation to launch mass vaccination drive for stray dogs from July

HealthDonald Trump pledges to cut US prescription drug prices by 80pc